PRESS RELEASE
Collaboration Aimed at Advancing Research and Helping to Improve Cancer Outcomes
SAN JOSE, Calif., March 24, 2023 - The Radiosurgery Society (RSS), a non-profit medical society dedicated to advancing the science and clinical practice of radiosurgery announced that The Lung Cancer Initiative at Johnson & Johnson has joined the RSS Sponsorship Alliance, adding to the list of highly respected corporations, institutions, organizations and societies to support the advancement of stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT) and advancing therapies.
"The Radiosurgery Society is delighted to welcome The Lung Cancer Initiative (LCI) at Johnson & Johnson to the Sponsorship Alliance. We look forward to active collaboration to advance the science and improve outcomes for patients with lung cancer," stated Najeeb Mohideen, MD, FRCR, FASTRO, FACR, President of the RSS Board of Directors.
The Lung Cancer Initiative at Johnson & Johnson is working to change the trajectory for lung cancer patients. It takes a multidisciplinary approach by combining the power of Johnson & Johnson’s expertise in Pharmaceuticals and MedTech with the goal of developing intratumoral therapies delivered directly to malignant tumors for less invasive, more precise treatment. *Johnson & Johnson Enterprise Innovation Inc. is the legal entity to this sponsorship.
"At the RSS, we strive to bring together multi-disciplinary teams from the medical device and pharmaceutical industries, healthcare, and scientific communities to work collectively toward the common goal of improving care for cancer patients. We are excited to work with The LCI at Johnson & Johnson on research efforts utilizing stereotactic radiotherapy to treat lung cancer," stated Joanne Davis, PhD, Executive Director of the RSS.
The RSS welcomes sponsoring organizations as partners in the RSS Sponsorship Alliance. These organizations champion the evolution of science and research clinical practices, patient safety and efficacy, technological innovations and global adoption of SRS/SBRT techniques. Sponsors join the ranks of highly-respected institutions, organizations, societies and corporations to support successful advancements in the field.
The Radiosurgery Society® is an international, medical professional, non-profit society consisting of physicians, physicists and healthcare professionals dedicated to advancing the education, science and clinical practice of stereotactic radiosurgery, stereotactic body radiation therapy and advancing therapies.
Contacts:
Stephanie Tomei
the Radiosurgery Society®
PressRelease@therss.org